1. Home
  2. HAS vs RGEN Comparison

HAS vs RGEN Comparison

Compare HAS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hasbro Inc.

HAS

Hasbro Inc.

HOLD

Current Price

$88.04

Market Cap

13.2B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$112.97

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAS
RGEN
Founded
1923
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
6.6B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
HAS
RGEN
Price
$88.04
$112.97
Analyst Decision
Strong Buy
Buy
Analyst Count
11
12
Target Price
$109.73
$167.67
AVG Volume (30 Days)
1.7M
1.3M
Earning Date
05-20-2026
05-05-2026
Dividend Yield
2.98%
N/A
EPS Growth
N/A
286.96
EPS
1.39
0.15
Revenue
$5,365,900,000.00
$141,236,000.00
Revenue This Year
$5.38
$14.30
Revenue Next Year
$6.48
$14.52
P/E Ratio
$63.16
$768.73
Revenue Growth
13.06
35.10
52 Week Low
$64.85
$100.99
52 Week High
$106.98
$175.77

Technical Indicators

Market Signals
Indicator
HAS
RGEN
Relative Strength Index (RSI) 39.31 45.60
Support Level $86.85 $111.09
Resistance Level $89.20 $129.77
Average True Range (ATR) 2.89 5.92
MACD -0.95 0.38
Stochastic Oscillator 9.39 42.03

Price Performance

Historical Comparison
HAS
RGEN

About HAS Hasbro Inc.

Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to 19 million digital tabletop players.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: